 - No prior systemic therapy or radiation therapy active against myeloma lasting more than four weeks duration. Any prior therapy must be completed a minimum of 21 days before starting study drugs. Enrollment of subjects who require radiotherapy which must be localized in its field size should be deferred until the radiotherapy is completed and 3 weeks have elapsed since the last date of therapy. 